Evidence map›Paper›PMID 23609441›Full record

ArticleThe Journal of biological chemistry2013

α-1,6-Fucosyltransferase (FUT8) inhibits hemoglobin production during differentiation of murine and K562 human erythroleukemia cells.

Hitoshi Sasaki, Takanori Toda, Toru Furukawa, Yuki Mawatari, Rika Takaesu, Masashi Shimizu, Ryohei Wada, Dai Kato, Takahiko Utsugi, Masaya Ohtsu and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. [FUT8 modulates galectin-3 expression to regulate TGF-β1-mediated fibrosis of lung fibroblasts].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Hitoshi SasakiFaculty of Industrial Science and Technology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585; Genome and Drug Research Center, Tokyo University of Science, Chiba 270-0101.
Takanori TodaFaculty of Industrial Science and Technology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585; Genome and Drug Research Center, Tokyo University of Science, Chiba 270-0101.
Toru FurukawaFaculty of Industrial Science and Technology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585; Genome and Drug Research Center, Tokyo University of Science, Chiba 270-0101.
Yuki MawatariFaculty of Industrial Science and Technology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585; Genome and Drug Research Center, Tokyo University of Science, Chiba 270-0101.
Rika TakaesuFaculty of Industrial Science and Technology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585; Genome and Drug Research Center, Tokyo University of Science, Chiba 270-0101.
Masashi ShimizuFaculty of Industrial Science and Technology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585; Genome and Drug Research Center, Tokyo University of Science, Chiba 270-0101.
Ryohei WadaFaculty of Industrial Science and Technology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585; Genome and Drug Research Center, Tokyo University of Science, Chiba 270-0101.
Dai KatoFaculty of Industrial Science and Technology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585.
Takahiko UtsugiGenome and Drug Research Center, Tokyo University of Science, Chiba 270-0101; Bio Matrix Research Inc., Chiba 270-0101, Japan.
Masaya OhtsuFaculty of Industrial Science and Technology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585.
Yasufumi MurakamiFaculty of Industrial Science and Technology, Department of Biological Science and Technology, Tokyo University of Science, Tokyo 125-8585; Genome and Drug Research Center, Tokyo University of Science, Chiba 270-0101; Bio Matrix Research Inc., Chiba 270-0101, Japan. Electronic address: yasufumi@rs.noda.tus.ac.jp.
Tokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erythropoiesis results from a complex combination of the expression of several transcription factor genes and cytokine signaling. However, the overall view of erythroid differentiation remains unclear. First, we screened for erythroid differentiation-related genes by comparing the expression profiles of high differentiation-inducible and low differentiation-inducible murine erythroleukemia cells. We identified that overexpression of α-1,6-fucosyltransferase (Fut8) inhibits hemoglobin production. FUT8 catalyzes the transfer of a fucose residue to N-linked oligosaccharides on glycoproteins via an α-1,6 linkage, leading to core fucosylation in mammals. Expression of Fut8 was down-regulated during chemically induced differentiation of murine erythroleukemia cells. Additionally, expression of Fut8 was positively regulated by c-Myc and c-Myb, which are known as suppressors of erythroid differentiation. Second, we found that FUT8 is the only fucosyltransferase family member that inhibits hemoglobin production. Functional analysis of FUT8 revealed that the donor substrate-binding domain and a flexible loop play essential roles in inhibition of hemoglobin production. This result clearly demonstrates that core fucosylation inhibits hemoglobin production. Third, FUT8 also inhibited hemoglobin production of human erythroleukemia K562 cells. Finally, a short hairpin RNA study showed that FUT8 down-regulation induced hemoglobin production and increase of transferrin receptor/glycophorin A-positive cells in human erythroleukemia K562 cells. Our findings define FUT8 as a novel factor for hemoglobin production and demonstrate that core fucosylation plays an important role in erythroid differentiation.

Indexed as

Cell DifferentiationAnimalsBiological Transport, ActiveFucoseFucosyltransferasesGlycophorinsHemoglobinsHumansK562 CellsLeukemia, Erythroblastic, AcuteMiceProtein Structure, TertiaryProto-Oncogene Proteins c-mybProto-Oncogene Proteins c-mycFucoseFucosyltransferasesGlycophorinsGlycoprotein 6-alpha-L-fucosyltransferaseHemoglobinsMYC protein, humanProto-Oncogene Proteins c-mybProto-Oncogene Proteins c-mycErythropoeisisFunctional GenomicsGlycosyltransferasesHemoglobinTranscriptomics

Identifiers

PMID23609441
PMCPMC3675616
OpenAlexW2004194067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.